Tuberculosis
Conditions
Interventions
Control
Intervention
Sponsors
University of California San Francisco
Makerere University College of Health Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Site-level Inclusion Criteria: 1. Diagnosed >10 PTB patients/month in 2017; 2. Not located within Kampala District; 3. Located within 225km of Kampala city; 4. PTB treatment success rate in 2016 of <80% Patient-level Inclusion Criteria: 1. Initiating Category I treatment for active pulmonary TB at a study facility during the study period
Exclusion criteria
Exclusion criteria: Site-level Exclusion Criteria: 1. Do not agree to participate in the trial Patient-level Exclusion Criteria: 1. Diagnosed with extra-pulmonary TB; 2. Diagnosed with or referred for evaluation of drug-resistant TB; 3. Does not own a mobile phone with SMS capabilities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion treated successfully | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion with persistence;Proportion lost to follow-up;Proportion enrolled on 99DOTS;Proportion of scheduled doses confirmed by phone call;Proportion of daily SMS sent by 99DOTS platform;Proportion of daily SMS received on patient handset;Proportion of weekly SMS sent by 99DOTS platform;Proportion of weekly SMS received on patient handset;Proportion of weekly SMS to which patients send a response;Proportion of patients followed-up via phone call or home visit if responding No or not responding to weekly check-in;Proportion of patients called or visited by DTU staff/CHW when missing >2 consecutive doses | — |
Countries
Uganda
Contacts
Public ContactRebecca Crowder
Research Associate
Outcome results
None listed